5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
The Respiratory Devices market is segmented by Type (Diagnostic and Monitoring Devices, Therapeutic Devices, and By Disposables) and Geography.
2018 - 2026
Fastest Growing Market:
The rise in the number of chronic obstructive pulmonary disease patients (COPD), TB, asthma, and pneumonia cases remains the major driver of the industry. Chronic respiratory diseases are chronic diseases that affect the airways and other parts of the lungs. Respiratory symptoms are among the major causes of consultation with doctors and physicians in primary health care centers. Some of the major preventable chronic respiratory disorders are asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, sleep apnea, and tuberculosis (principally, multi-drug resistant tuberculosis). Chronic respiratory diseases affect more than one billion people, globally, as per the Global Asthma report, 2018. Asthma is one of the largest contributors to this figure, affecting children, adults, and elderly people. There is a high prevalence of severe asthma in the emerging markets of MEA and Latin America, compared to the mid-range prevalence in North America, Europe, and Asia-Pacific. More recently, the COVID-19 outbreak has also increased the demand for respiratory devices like Ventilators.
Moreover, the technological advances, increasing portability, and ease of operation of devices are fueling the expansion of respiratory devices in home and alternate care settings, across the world. In addition, government and non-profit initiatives, such as the global initiative for asthma (GINA), awareness programs, and funding research studies have influenced the industry.
As per the scope of the report, respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. It may also include a breathing apparatus used for resuscitation, by forcing oxygen into the lungs of a person who has undergone asphyxia.
Report scope can be customized per your requirements. Click here.
Recently, therapeutic devices like Vetilators have been in high demand due to outbreak of COVID-19. A ventilator is a machine that provides mechanical ventilation by moving breathable air into and out of the lungs, to deliver breaths to a patient who is physically unable to breathe, or breathing insufficiently. Modern ventilators are computerized microprocessor-controlled machines, but patients can also be ventilated with a simple, hand-operated bag valve mask. Ventilators are chiefly used in intensive-care medicine, home care, and emergency medicine and in anesthesiology.
Outbreak of COVID-19 has been global and enourmous. As per Worldometer data, the total number of cases of COVID-19 increased from 11,950 in January 2020 to 86,604 in February 2020 to 859,798 by the end of March 2020. As of 12th April, 2020, there are a total of 1,852,365 globally. The pandemic has created a need for ventilators, especially for elderly, for therapeutic assistance. This is exepted to boost the market grwoth.
To understand key trends, Download Sample Report
North America accounts for the largest share of the market studied. This can be primarily attributed to the increasing prevalence of respiratory diseases. According to the data published by the World Health Organization (WHO), the Global Burden of Disease Study reported a prevalence of 251 million cases of Chronic Obstructive Pulmonary Disease (COPD) globally in 2016. Moreover, the burden of COVID-19 outbreak was enormous.
The presence of major players in the region, such as GE Healthcare, Medtronic, and ResMed Inc., are also augmenting the growth of the market.
To understand geography trends, Download Sample Report.
The respiratory devices market consists of several major players. The companies are implementing certain strategic initiatives, such as a merger, new product launch, acquisition and partnerships that help them in strengthening their market position. For instance, in May 2017, the Drägerwerk AG & CO. KGAA introduced Oxylog VE300, a newly developed emergency and transport ventilator that is particularly apt for use outside of the hospital environment.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Respiratory Disorders, such as COPD, TB, Asthma, and Sleep Apnea
4.2.2 Technological Advancements and Increasing Applications in Homecare Setting
4.3 Market Restraints
4.3.1 High Cost of Devices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type
5.1.1 Diagnostic and Monitoring Devices
220.127.116.11 Sleep Test Devices
18.104.22.168 Peak Flow Meters
22.214.171.124 Pulse Oximeters
126.96.36.199 Other Diagnostic and Monitoring Devices
5.1.2 Therapeutic Devices
188.8.131.52 CPAP Devices
184.108.40.206 BiPAP Devices
220.127.116.11 Oxygen Concentrators
18.104.22.168 Other Therapeutic Devices
22.214.171.124 Breathing Circuits
126.96.36.199 Other Disposables
5.2.1 North America
188.8.131.52 United States
184.108.40.206 United Kingdom
220.127.116.11 Rest of Europe
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
5.2.4 Middle-East & Africa
126.96.36.199 South Africa
188.8.131.52 Rest of Middle-East & Africa
5.2.5 South America
184.108.40.206 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 DeVilbiss Healthcare LLC
6.1.2 Dragerwerk AG
6.1.3 Fisher & Paykel Healthcare Ltd
6.1.4 GE Healthcare
6.1.5 Getinge AB
6.1.6 GlaxoSmithKline PLC
6.1.7 Invacare Corporation
6.1.8 Koninklijke Philips NV
6.1.9 Medtronic PLC
6.1.10 ResMed Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments